TW585766B - Combination of active ingredients for the treatment of senile dementia of the Alzheimer type - Google Patents
Combination of active ingredients for the treatment of senile dementia of the Alzheimer type Download PDFInfo
- Publication number
- TW585766B TW585766B TW087117874A TW87117874A TW585766B TW 585766 B TW585766 B TW 585766B TW 087117874 A TW087117874 A TW 087117874A TW 87117874 A TW87117874 A TW 87117874A TW 585766 B TW585766 B TW 585766B
- Authority
- TW
- Taiwan
- Prior art keywords
- tetrahydropyridine
- alkyl
- ethyl
- trifluoromethylphenyl
- biphenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714322A FR2771007B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
FR9714324A FR2771006B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
TW585766B true TW585766B (en) | 2004-05-01 |
Family
ID=26233932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW087117874A TW585766B (en) | 1997-11-14 | 1998-10-28 | Combination of active ingredients for the treatment of senile dementia of the Alzheimer type |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1030671A1 (ko) |
JP (1) | JP2001523642A (ko) |
KR (1) | KR100599350B1 (ko) |
CN (1) | CN1243540C (ko) |
AU (1) | AU743228B2 (ko) |
BG (1) | BG64819B1 (ko) |
BR (1) | BR9814035A (ko) |
CA (1) | CA2309966A1 (ko) |
CO (1) | CO4980891A1 (ko) |
DZ (1) | DZ2649A1 (ko) |
EA (1) | EA003255B1 (ko) |
EE (1) | EE04235B1 (ko) |
HU (1) | HUP0100098A3 (ko) |
ID (1) | ID24933A (ko) |
IL (2) | IL136122A0 (ko) |
IS (1) | IS5482A (ko) |
MY (1) | MY120461A (ko) |
NO (1) | NO20002450L (ko) |
NZ (1) | NZ504420A (ko) |
OA (1) | OA11464A (ko) |
PL (1) | PL194597B1 (ko) |
SA (1) | SA98190747B1 (ko) |
SK (1) | SK286040B6 (ko) |
TR (1) | TR200001262T2 (ko) |
TW (1) | TW585766B (ko) |
UY (1) | UY25247A1 (ko) |
WO (1) | WO1999025363A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100375619C (zh) * | 2002-06-14 | 2008-03-19 | 富山化学工业株式会社 | 改善脑功能的药物组合物及其用途 |
PT1529116E (pt) * | 2002-08-07 | 2009-09-10 | Novartis Ag | Métodos para o tratamento da demência com base no genótipo da apo e |
CN1520818A (zh) * | 2003-02-09 | 2004-08-18 | 山东绿叶天然药物研究开发有限公司 | 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物 |
JP2008525313A (ja) | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
DK3498692T3 (da) | 2014-01-31 | 2022-05-16 | Cognition Therapeutics Inc | Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration |
BR112019023851A2 (pt) * | 2017-05-15 | 2020-08-18 | Cognition Therapeutics, Inc. | compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas |
WO2019182319A1 (ko) * | 2018-03-20 | 2019-09-26 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
KR102224917B1 (ko) | 2018-03-20 | 2021-03-09 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
CN109265391B (zh) * | 2018-11-13 | 2021-11-19 | 枣庄学院 | 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
CN1126546C (zh) * | 1995-03-06 | 2003-11-05 | 英特纽隆制剂药有限公司 | 使用胞磷胆碱减少梗塞面积 |
FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
-
1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/es unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/zh not_active IP Right Cessation
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 SK SK711-2000A patent/SK286040B6/sk unknown
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/ko not_active IP Right Cessation
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/pt not_active Application Discontinuation
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/xx unknown
- 1998-11-09 PL PL98340500A patent/PL194597B1/pl not_active IP Right Cessation
- 1998-11-09 EE EEP200000290A patent/EE04235B1/xx not_active IP Right Cessation
- 1998-11-09 CN CNB988130947A patent/CN1243540C/zh not_active Expired - Fee Related
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/hu unknown
- 1998-11-09 EP EP98954538A patent/EP1030671A1/fr not_active Withdrawn
- 1998-11-09 EA EA200000412A patent/EA003255B1/ru not_active IP Right Cessation
- 1998-11-09 IL IL13612298A patent/IL136122A0/xx not_active IP Right Cessation
- 1998-11-09 ID IDW20000860A patent/ID24933A/id unknown
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/ja not_active Withdrawn
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/fr not_active Application Discontinuation
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/xx active
- 1998-11-12 UY UY25247A patent/UY25247A1/es not_active IP Right Cessation
- 1998-11-14 SA SA98190747A patent/SA98190747B1/ar unknown
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
-
2000
- 2000-05-09 IS IS5482A patent/IS5482A/is unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/no unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/bg unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2282654C (en) | Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder | |
TW201028147A (en) | Dosage regimen of an S1P receptor agonist | |
EP3265087B1 (en) | Method of treatment with tradipitant | |
CA2582436C (en) | Combinations of nicotinic acetylcholine alpha 7 receptor agonists | |
WO2013029762A1 (en) | Morphinan-derivatives for treating diabetes and related disorders | |
AU2006251893A1 (en) | Scopolamine for the treatment of depression and anxiety | |
TW585766B (en) | Combination of active ingredients for the treatment of senile dementia of the Alzheimer type | |
NZ539711A (en) | Solid preparation | |
WO1995007690A1 (en) | Composition and method for treating nicotine craving in smoking cessation | |
EA015483B1 (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРА p38 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ | |
TW517048B (en) | Pharmaceutical composition for treating depressive disorders and bipolardisorders comprising (+)-Α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol | |
AU2016218950C1 (en) | Analgesic formulation | |
US20080125442A1 (en) | Cathepsin K Inhibitors and Atherosclerosis | |
NL8002041A (nl) | Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel. | |
HU206829B (en) | Process for producing pharmaceutical compositions containing buspirone against smoking and obesity | |
KR20010024768A (ko) | 혈관성 두통에 대한 국소 마취제의 신규 용도 | |
JP2003503459A (ja) | パラセタモール及びブスピロンを含有した鎮痛性作用を有する新規医薬組成物 | |
JP2001511159A (ja) | オキシムを含むシナプス機能障害の処置用医薬組成物 | |
CN110167553A (zh) | 新颖的剂量方案 | |
EP1524982B1 (de) | Medikament und verfahren zur verringerung des alkohol-und/oder tabakkonsums | |
CZ20001734A3 (cs) | Farmaceutická kompozice a její použití | |
MXPA00004600A (en) | Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia | |
CN116236559A (zh) | 眼镜蛇科蛇突触后神经毒素单体分子在治疗药物及酒精依赖或戒断症状上的应用 | |
WO1988007867A1 (en) | Nootropic | |
WO2002051416A1 (fr) | Medicaments ameliorant les comportements de la vie courante chez des personnes atteintes de la maladie d'alzheimer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |